| Parameter | Score |
|---|---|
| 1. Scale | B |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | B |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | B |
| 7. Steady State | B |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | C |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | C8,10,12 |
| Comment | scale:%, CVA with CQI |
| Parameter | Score |
|---|---|
| Matrix | Whole Blood EDTA |
| Measurand | Haemoglobin A1c (NGSP) |
| Unit | % / _ |
| Overall Analytical Principle Method | Spectrophotometry; UV/VISIBLE |
| Number of Subjects | 12 |
| Number of Subjects included in BV estimation | 12 |
| Ethinicity | Caucasian |
| Age Mean / Median | |
| Age Min | |
| Age Max | |
| Age SD | |
| Number of Males | |
| Number of Females | |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 5,4 months |
| Study Duration Units | Week |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | |
| Interval Units | Week |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 10 |
| Average Number of Samples Used for BV Estimation | 10.0 |
| Average Number of Replicates | 0.0 |
| Estimates of CVi | 1.9 |
| Calculated Confidence Intervals of CVi | Lower: 0.00, Upper: 2.66 |
| Estimates of CVg | 6.8 |
| Calculated Confidence Intervals of CVg | Lower: 4.84, Upper: 11.29 |
| Analytical CV | 2.2 |
| Calculated Confidence Intervals of Analytical CV | Lower: 1.58, Upper: 3.63 |
| Measurand Mean | 4.01 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |